Bringing the fundamentals into focus…
Back to Inspire Medical Systems, Inc.
How Inspire Medical Systems, Inc. stacks up
INSP · against 428 other Healthcare companies of similar size
Valuation
75/ 100
Above the middle of the pack.
Ranked #124 of 429 · scores higher than 70% of peers
Bars: peers in each 10-point band of the valuation score49 peers with a valuation score of 70–79, including INSP · Click a bar to see the companies
Why valuation scores 75?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its earnings yield and free cash flow yield, which are stronger than most Healthcare peers.
- EBITDA yield is close to the peer norm. EBITDA yield: 4.8% vs peer median 4.0%
- more free cash flow for the price paid: stronger than 86% of peers. Free cash flow yield: 6.5% vs peer median 0.0%
- higher earnings for the price paid: stronger than 89% of peers. Earnings yield: 7.5% vs peer median 1.5%
Metric by metric
Position: dot = INSP, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | INSP | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 418 reported | 7.3% | 1.8% | 88% | 30% | |
| EBITDA yieldHigher is better · 428 reported | 4.8% | 4.5% | 53% | 50% | |
| Free cash flow yieldHigher is better · 196 reported | 6.5% | -0.3% | 83% | 20% | |
| Book yieldHigher is better · 420 reported | 46.1% | 36.3% | 63% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around INSPScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score